Adjunctive therapy for Malaria: 5-deoxy-Δ12,14-Prostaglandin J2 (15-deoxy-Δ12,14-PGJ2) increases Ferroportin expression, decreases intracellular iron accumulation, inhibits cellular damage, prevents hemolysis, and inhibits malaria infection, via upregulation of its target gene, 5/July/2018, 7.29 am

"Help us make a difference by supporting our mission with your generous donation."

Spread the love


Spread the love
small_c_popup.png

Let's have a chat!

Sign-up for our newsletter to learn more about upcoming Genomediscovery Forums!